Bioventus Inc. (BVS) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
BVS currently has 67.3M outstanding shares. with significant dilution risk as 42.4M authorized shares could dilute existing holders by 63.0%. The company has minimally diluted shareholders by 6.08% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 06, 2026 |
10-Q filing | 67.3M shares outstanding |
67M | 42M |
| Nov 04, 2025 |
10-Q filing | 66.9M shares outstanding |
67M | 42M |
| Aug 06, 2025 |
10-Q filing | 66.5M shares outstanding |
67M | 42M |
| May 06, 2025 |
10-Q filing | 66.0M shares outstanding |
66M | 42M |
| Mar 11, 2025 |
10-K filing | 64.5M shares outstanding |
65M | 42M |
| Nov 05, 2024 |
10-Q filing | 65.3M shares outstanding |
65M | 42M |
| Oct 25, 2024 |
S-3 filing: Bioventus Inc. files an S-3 form to register the offering of Class A Common Stock, Preferred Stock, and Debt Securities, with a proposed amount of $200,000,000, and Class A Common Stock offered by selling securityholders, with 35,038,052 shares. |
64M | 42M |
| Aug 06, 2024 |
10-Q filing | 64.1M shares outstanding |
64M | 7.4M |
| May 07, 2024 |
10-Q filing | 63.4M shares outstanding |
63M | 7.4M |
| Mar 12, 2024 |
10-K filing | 62.6M shares outstanding |
63M | 7.4M |
| Nov 07, 2023 |
10-Q filing | 62.8M shares outstanding |
63M | 7.4M |
| Aug 08, 2023 |
10-Q filing | 62.6M shares outstanding |
63M | 7.4M |
| May 16, 2023 |
10-Q filing | 62.1M shares outstanding |
62M | 7.4M |
| Mar 31, 2023 |
10-K filing | 61.4M shares outstanding |
61M | 7.4M |
| Nov 21, 2022 |
10-Q filing | 61.7M shares outstanding |
62M | 7.4M |
| Aug 12, 2022 |
10-Q filing | 61.5M shares outstanding |
61M | 7.4M |
| May 11, 2022 |
10-Q filing | 60.5M shares outstanding |
60M | 7.4M |
| Mar 11, 2022 |
10-K filing | 60.6M shares outstanding |
61M | 7.4M |
| Nov 10, 2021 |
10-Q filing | 59.4M shares outstanding |
59M | 7.4M |
| Aug 11, 2021 |
10-Q filing | 41.8M shares outstanding |
42M | 7.4M |
| May 13, 2021 |
10-Q filing | 41.8M shares outstanding |
42M | 7.4M |
| Feb 10, 2021 |
S-1/A filing: This S-1/A filing from Bioventus Inc. on 2021-02-10 details an offering of 7,350,000 shares of Class A common stock at an assumed price of $17.00 per share, with an underwriters' option to purchase an additional 1,102,500 shares. |
38M | 7.4M |
| Feb 04, 2021 |
S-1/A filing: This S-1/A filing relates to an offering of Class A common stock. 7,350,000 shares are being offered to the public, with an additional 1,102,500 shares available through the underwriter's option. Also included are 30,347,158 shares of Class A common stock to be issued to Former LLC Owners. Following the offering, there will be 37,697,158 shares of Class A common stock and 16,534,814 shares of Class B common stock outstanding. |
38M | 39M |
| Jan 20, 2021 |
S-1 filing: This is an S-1 filing for Bioventus Inc. related to an initial public offering of Class A common stock. |
N/A | 0 |